<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0048">
 <label>48.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Fanucchi</surname>
    <given-names>LC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Walsh</surname>
    <given-names>SL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Thornton</surname>
    <given-names>AC</given-names>
   </name>, 
   <name name-style="western">
    <surname>Nuzzo</surname>
    <given-names>PA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lofwall</surname>
    <given-names>MR</given-names>
   </name>
  </person-group>
  <article-title>Outpatient parenteral antimicrobial therapy plus buprenorphine for opioid use disorder and severe injection-related infections</article-title> [published online ahead of print 26 July 2019]. 
  <source>Clin Infect Dis</source> doi: 10.1093/cid/ciz654.
 </mixed-citation>
</ref>
